Kong Wai Tan

Dr. Kong Wai Tan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of Molecular Structure
Verified
Journal Article
Closed access
SSSavina Savir
Savina Savir
JLJonathan Wee Kent Liew
Jonathan Wee Kent Liew
IVIndra Vythilingam
Indra Vythilingam
YLYvonne Ai Lian Lim
Yvonne Ai Lian Lim
CTChun Hoe Tan
Chun Hoe Tan
KTKong Wai Tan
Kong Wai Tan

1 April 2021 in Optical Materials
Verified
Journal Article
Closed access
PCPoh Wei Cheah
Poh Wei Cheah
MHMok Piew Heng
Mok Piew Heng
HSHazwani Mat Saad
Hazwani Mat Saad
KSKae Shin Sim
Kae Shin Sim
KTKong Wai Tan
Kong Wai Tan

1 August 2021 in Journal of Molecular Structure
Verified
Journal Article
Closed access
NPNur Amira Solehah Pungut
Nur Amira Solehah Pungut
MHMok Piew Heng
Mok Piew Heng
HSHazwani Mat Saad
Hazwani Mat Saad
KSKae Shin Sim
Kae Shin Sim
VLVannajan Sanghiran Lee
Vannajan Sanghiran Lee
KTKong Wai Tan
Kong Wai Tan

1 December 2021 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
WCWei Chuen Chan
Wei Chuen Chan
HSHazwani Mat Saad
Hazwani Mat Saad
KSKae Shin Sim
Kae Shin Sim
VLVannajan Sanghiran Lee
Vannajan Sanghiran Lee
CAChee Wei Ang
Chee Wei Ang
KTKong Wai Tan
Kong Wai Tan

1 June 2021 in Journal of Photochemistry and Photobiology A: Chemistry
Verified
Journal Article
Closed access
NPNur Amira Solehah Pungut
Nur Amira Solehah Pungut
HSHazwani Mat Saad
Hazwani Mat Saad
KSKae Shin Sim
Kae Shin Sim
KTKong Wai Tan
Kong Wai Tan

10 November 2014 in RSC Advances
Verified
Journal Article
Closed access
PDF file
SCShin Thung Chew
Shin Thung Chew
KLKong Mun Lo
Kong Mun Lo
SSSaravana Kumar Sinniah
Saravana Kumar Sinniah
KSKae Shin Sim
Kae Shin Sim
KTKong Wai Tan
Kong Wai Tan
Four new copper(II) complexes containing triphenylphosphonium conjugated salicylaldehyde-(4-fluorobenzhydrazone), (L) with the formulation [CuL]Cl(1), [Cu(phen)L]Cl(2), [Cu(bpy)L]Cl(3), [Cu(dmbpy)L]Cl(4), (where L = doubly deprotonated hydrazone; phen = 1,10′-phenanthroline; bpy = 2,2′-bipyridine; dmbpy = 5,5′-dimethyl-2,2′-bipyridine) have been synthesized. The compounds were characterized by spectroscopic methods and, in the case of crystalline products, by X-ray crystallography. The topoisomerase I (topo I) inhibition, DNA binding and cleavage activities and cytotoxicity of the compounds were studied. A DNA relaxation study demonstrated that all the copper complexes successfully inhibit topo I enzyme by binding to topo I as the preferred pathway. Complex 1 is the most active with starting inhibitory concentration ≈20 μM. The planarity of the tridentate hydrazone Schiff base ligand and the diimine co-ligands increase the binding affinity to DNA. The presence of the 1,10′-phenanthroline co-ligand in complex 2 induces plasmid DNA (pBR322) cleavage without exogenous agents. It is noteworthy that the addition of diimine co-ligands to the copper(II) complex enhanced the cytotoxicity of the compounds, especially against the human prostate adenocarcinoma cell line (PC-3). Complex 2 exhibits the highest activity against PC-3 with the IC50 value of 2.47 ± 0.37 μM. Annexin V/propidium iodide analysis showed that compound 1 induces apoptotic and necrotic cell death, whereas compound 2–4 work mainly through apoptosis.